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Most of the Human diseases affecting westernized countries are associated with
dysbiosis and loss of microbial diversity in the gut microbiota. The Western way of life,
with a wide use of antibiotics and other environmental triggers, may reduce the number
of bacterial predators leading to a decrease in microbial diversity of the Human gut. We
argue that this phenomenon is similar to the process of ecosystem impoverishment in
macro ecology where human activity decreases ecological niches, the size of predator
populations, and finally the biodiversity. Such pauperization is fundamental since it
reverses the evolution processes, drives life backward into diminished complexity,
stability, and adaptability. A simple therapeutic approach could thus be to reintroduce
bacterial predators and restore a bacterial diversity of the host microbiota.
Keywords: dysbiosis, ecosystem, predator, western lifestyle, chronic human conditions, Bdellovibrio
bacteriovorus
INTRODUCTION
The gut is the largest interface (200m2) between the host and its external milieu. It plays an
important part in the metabolism of nutriments and water absorption. Furthermore, immune
cells of the Gut Associated Lymphoid Tissue (GALT) are more numerous than those from other
secondary lymphoid tissues contained in the whole body. They interact with trillions of bacteria,
archaea and eukaryotes forming a complex ecosystem: the gut microbiota. Almost 80% of microbes
observed by microscopic examination of fecal specimens are not recoverable by culture (Suau
et al., 1999). Thus, until the recent development of culture-independent methods, which combine
isolation and sequencing of nucleic acids and powerful bioinformatics analyses, the gut microbiota
was seen as an ignored organ or a black box.
Our knowledge on the Human gut microbiota is quickly increasing. In a given individual, the
microbiota is relatively stable after the first months of life (Koenig et al., 2011). At the population
level, the microbiota is also supposed to be stable and selected by evolution (Ochman et al.,
2010; Jalanka-Tuovinen et al., 2011). However, the commensal microbiota can be qualitatively and
quantitatively modulated by the environment (Huttenhower et al., 2012). Recent changes in the
environment may thus have altered the mutually beneficial interaction toward another stable but
harmful balance (Lozupone et al., 2012; Shade et al., 2012).
Sometimes and unexpectedly, links have been established between diseases of
industrialized countries and altered patterns of the gut microbial ecosystem collectively
known as intestinal dysbiosis. The concept of dysbiosis refers to an unbalanced
microbiota, which is most of the time supposed to be harmful. The effectiveness of fecal
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microbiota transplantation in the cases of Clostridium difficile
associated colitis or T2D supports this opinion (Vrieze et al.,
2012; Sha et al., 2014). As a result, “understanding the structure
and function of the human symbiont communities might become
the first great breakthrough of twenty-first century medicine”
(Guarner, 2014).
Loss of microbiota diversity (LOMD) appears as the most
constant finding of intestinal dysbiosis. By analogy with macro
ecosystems, we propose here that it is related to the loss of
bacterial predators associated with our modernWestern lifestyle.
Interestingly, this hypothesis suggests that the reintroduction of
bacterial predators in our digestive ecosystem may be an option
for improving/restoring the gut microbiota diversity and for
treating at-risk people (Jakobsson et al., 2014).
HUMAN DISEASES, WESTERN LIFESTYLE
AND MICROBIOTA DIVERSITY: A
TRIPARTITE ASSOCIATION
Human Diseases Are Often Associated
with the Modern Western Lifestyle
In the past decades, the prevalence of numerous diseases
has sharply increased, a phenomenon initially observed in
Western countries and more recently in developing countries
(Figure 1,Table 1). These complex genetic disorders include
“immune related” diseases like allergy, inflammatory bowel
diseases (IBD), type 1 diabetes mellitus (T1D), multiple sclerosis
(MS) but also colorectal cancer ormetabolic disorders like obesity
and type 2 diabetes mellitus (T2D; Mayr et al., 2003; Eder
et al., 2006; Harjutsalo et al., 2008; Andersson et al., 2014).
Unrecognized environmental changes necessarily explain these
outbreaks. The higher occurrence of some of these diseases
(i.e., asthma, T1D, MS, obesity, T2D, colorectal cancer) among
migrants (Bodansky et al., 1992; Hammond et al., 2000; Grüber
et al., 2002; Pinheiro et al., 2009; Creatore et al., 2010), especially
when emigrating before the age of 5 years (Kuehni et al., 2007)
confirms a role of early environmental risk factors.
The Reduction in Intestinal Microbiota
Diversity Is Associated with Human
Diseases
Among the huge body of literature describing disease-associated
microbiota, LOMD appears as a common feature of most
dysbioses. In digestive diseases such as Crohn’s disease (CD)
(an IBD condition; Sha et al., 2013; Matsuoka and Kanai,
2015), irritable bowel syndrome (IBS), with (Carroll et al.,
2012) or without diarrhea (Durbán et al., 2012) and colorectal
cancer (Ahn et al., 2013), LOMD is constantly observed. The
duodenum-associated microbiota of celiac disease patients is also
less diversified (Schippa et al., 2010). LOMD is a risk factor
of relapse in Clostridium difficile colitis (Chang et al., 2008).
Obesity is associated with altered representations of specific
bacterial species, which often differ between studies, but LOMD
is constantly retrieved with up to 20% loss of phylogenetic
diversity and one third difference in terms of gene number
(Turnbaugh et al., 2009; Cotillard et al., 2013; Tagliabue and Elli,
FIGURE 1 | Associative links between Western lifestyle, Human
conditions, and loss of microbial diversity (LOMD). On one hand, most of
the Human diseases affecting westernized countries are associated with
LOMD and on the other hand, some western lifestyle patterns cause LOMD.
Then, LOMD appears to play a central role linking western lifestyle and
western chronic human conditions (see also Table 1). *LOMD not assessed.
2013). Finally and more surprisingly, LOMD is also reported in
non-digestive diseases such as autism (Kang et al., 2013). It thus
appears that LOMD is a general feature associated with several
Human conditions.
However, these associations might be the consequence rather
than the cause of the disease. Several authors have questioned
this chicken-egg problem and found arguments for a causal
effect of LOMD on Human diseases. LOMD was found in CD
(54 ribotypes in CD patients vs. 88 in healthy controls) not
only in case of flare but also in case of remission (Manichanh
et al., 2006) suggesting that it is not a consequence of gut
inflammation. In healthy people investigated for T1D markers,
themicrobial diversity was lower in fecal samples of children with
at least two disease-associated autoantibodies when compared
to autoantibody-negative children matched for age, sex, early
feeding history, and HLA-genotyping (De Goffau et al., 2013).
In two studies following children at risk for T1D longitudinally
from birth, a decrease of microbial diversity occurred just before
the occurrence of anti-islet cell antibodies and subsequently
T1D (Giongo et al., 2010; Kostic et al., 2015). Among obese
individuals, a decrease of richness assessed by a low microbiome
gene count was predictive of response to diet (Cotillard et al.,
2013).
Consistently, in two prospective studies, LOMD measured
during the first week of life was predictive of allergic
manifestations at ages of 12 and 18 months (Wang et al., 2008;
Ismail et al., 2012) and asthma at the age of 7 years (Abrahamsson
et al., 2014). Decrease of microbial diversity also predicts the
response to treatments. For example, in Ulcerative Colitis (UC),
children who responded to corticosteroids had a more diverse
microbiota than non-responders (Michail et al., 2012). LOMD
is also a risk factor of relapse after intestinal resection in CD
(Dey et al., 2013). Finally, it seems that CD can be triggered by
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TABLE 1 | Human diseases and western lifestyle: prevalence and LOMD.





Crohn’s Disease + Manichanh et al., 2006; Dey et al.,
2013; Sha et al., 2013; Matsuoka
and Kanai, 2015
+ Lehtinen et al., 2011
Ulcerative Colitis + Michail et al., 2012; Sha et al., 2013 + Lehtinen et al., 2011
Type 1 diabetes mellitus + Giongo et al., 2010; De Goffau
et al., 2013; Kostic et al., 2015
+ Harjutsalo et al., 2008;
Andersson et al., 2014
Multiple Sclerosis ND Bhargava and Mowry, 2014 + Mayr et al., 2003
Celiac Disease + Schippa et al., 2010 + Lohi et al., 2007
Allergy + Wang et al., 2008; Ismail et al.,
2012; Abrahamsson et al., 2014
+ Latvala et al., 2005; Eder et al.,
2006
METABOLIC DISEASES
Obesity + Turnbaugh et al., 2009 + WHO | Obesity and overweight
Type 2 diabetes mellitus - + WHO | Diabetes
CANCER
Colorectal cancer + Ahn et al., 2013 + European Cancer Observatory
http://eco.iarc.fr/
OTHERS
Irritable Bowel Syndrome + Carroll et al., 2012; Durbán et al.,
2012
– Lovell and Ford, 2012
Recurrent Clostridium difficile Infection + Chang et al., 2008 ND
Autism + Kang et al., 2013 + Atladottir et al., 2015
Necrotising Enterocolitis + Stewart et al., 2013 ND
Graft Versus Host Disease + Jenq et al., 2012 ND
WHO | Diabetes WHO. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/ [Accessed September 29, 2015].
WHO | Obesity and overweight WHO. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/ [Accessed September 29, 2015].
ND, No Data.
a dysbiotic gut microbiota in a mouse model (Schaubeck et al.,
2015).
Altogether, these observations strongly argue for a causal
effect of LOMD in several Human conditions.
The Western Lifestyle May Explain the
Reduced Diversity of the Intestinal
Microbiota
LOMD is a feature of industrialized countries. Among the many
candidate risk factors causing the LOMD, some of them can
be highlighted, such as lifestyle, eating behaviors, disruption of
biological clock and antibiotic consumption (Figure 1).
The microbiota of Malawian and Venezuelan people are
more diversified than their US children and adult counterparts
(Yatsunenko et al., 2012). Similar differences were found when
comparing Bangladeshi to American children (Lin et al., 2013).
More recently, the analysis of gut microbiota patterns of rural
Papua New Guineans compared with those of people from USA
showed that westernization may decrease bacterial dispersal rates
and alter the microbiota structure (Martínez et al., 2015). The
Human hunter-gatherers Hadza of Tanzania—where people still
live outside without access to antibiotics and treated water—had
higher levels of microbial richness and biodiversity than Italian
urban controls (Schnorr et al., 2014).
Different eating behaviors that are known to rapidly affect the
intestinal microbiome (David et al., 2013) are obvious possible
explanations. For example, fiber consumption may explain the
differences observed between children from Burkina Faso and
Italy (De Filippo et al., 2010). Recently, the impact of diet on
the microbiota has been reviewed, and it turns out that fiber rich
diet enhances gut microbiota diversity (Simpson and Campbell,
2015; for a more complete critical review on gut microbiota and
diet, see Graf et al., 2015). However, these differences might not
only be due to diet (Wu et al., 2016) and alternative hypotheses
may be raised. For example, the practice of cesarean section has
grown steadily since the second half of the twentieth century
in Western countries, reaching an average of 26.9% of birth
in OECD countries (OECD, 2013) but only 5% in developing
countries (Betrán et al., 2007). Children born by cesarean section
have a LOMDwhen compared to those born vaginally (Jakobsson
et al., 2014).
Modern lifestyle might trigger a disruption of the biological
clock with consequences for the host and the microbiota. Several
characteristics of modern life style such as working shifts, stress,
jet lag, unusual feeding patterns have been shown to disrupt
the biological clock. The link between microbiota, its host
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and diurnal oscillation was well-described for the squid-Vibrio
fischerii symbiosis (Wier et al., 2010).More recently, the intestinal
microbiota in both mice and humans has been shown to exhibit
diurnal oscillations, that when disrupted, led to a LOMD and
dysbiosis (Thaiss et al., 2014).
Antibiotics (ATB) are other candidate risk factors. Naturally
produced by many microorganisms, ATB have been developed
by humans after the 30’s. Beyond human medicine, antibiotics
are now widely used especially for animal rearing, to the point
where they are now markers of human economic activity.
Humans cause a massive spread of ATB in the environment
with significant impacts on the bacterial ecosystems of water,
soil, and plants (Sarmah et al., 2006; Dolliver and Gupta, 2008;
Martinez, 2009). ATB profoundly alter the structure of the
intestinal microbiota (Buffie et al., 2012) and reduce the bacterial
diversity (Dethlefsen et al., 2008; Pérez-Cobas et al., 2013; Zhao
et al., 2014). Of note, ATB use during infancy and childhood is
associated with increased incidences of asthma, atopic dermatitis,
MS, IBD, juvenile idiopathic arthritis and obesity (Zeissig and
Blumberg, 2014; Horton et al., 2015; Schwartz et al., 2015).
LOMD IS A HALLMARK OF A DEFECTIVE
EQUILIBRIUM BETWEEN PREDATORS
AND THEIR PREYS
What Shapes Microbial Communities?
Whatever the relevant environmental risk factor(s) playing a role
in industrialized countries, the way it impacts the composition of
the gut microbiota remains to be explained.
Microbial communities harbor a wide range of ecological
interactions which may be of five different types including
(i) mutualism, where both the participants are benefited; (ii)
amensalism, where one organism is inhibited or destroyed and
the other is unaffected; (iii) commensalism, where one partner
gets the advantage without any help or harm to the other;
(iv) competition, where both the participants harm each other;
and (v) predation and parasitism, where one gets benefited out
of the other (Faust and Raes, 2012). All of these interactions
are supposed to shape the community assembly. For instance,
cooperation through metabolic exchange between species has
been shown to be predictive for some co-occurrences (Zelezniak
et al., 2015). However, the way diversity is shaped and persists is
still poorly understood for the complex network of interactions
within the gut.
Thank to phylogenetic approaches, knowledge on
mechanisms governing microbial communities has improved
over the last few years, filling the gap between knowledge on
macrobial and microbial ecosystems. According to Vellend’s
conceptual synthesis of community ecology (Vellend, 2010),
diversity at local scales (alpha diversity) is shaped by a
combination of four processes: dispersal, local diversification,
environmental selection and ecological drift (or demographic
stochasticity; Costello et al., 2012). Inside the gut ecosystem, such
processes could drive the microbiota community and specifically
the microbiota diversity toward short-term and long-term co-
evolution. Then, we thought to be inspired by macro ecological
theories to encompass to what extend predation could play a role
in driving gut microbiota diversity.
The Human Activities Impact the
Predator/Prey Equilibrium
In macro ecology, it is now recognized that human activity
causes a decrease in biodiversity of unprecedented proportions
(Butchart et al., 2010). Among the many parameters that are
under the pressure from Human activities, a major one is the
loss of large predators, i.e., those who are at the top of the
food chain in a given ecosystem. In 1966, Paine was the first
to observe a decrease of mussel species in a marine ecosystem
when removing the starfishes (Paine, 1966). He hypothesized
that “the local biodiversity was directly related to the efficiency
with which predators prevent the monopolization of the major
environmental requisites by one species.” Similarly, sea otters
protect kelp forests from damage by sea urchins (Szpak et al.,
2013). Australian natives introduced dingo (Canis lupus Dingo)
at least 3500 years ago. As it preyed upon livestock, the dingo
has been the target of extermination programs for the last two
centuries. Hereby, it was seen that the loss of dingoes has resulted
in the depletion of plant biomass through a dysregulation of
herbivore population (Letnic et al., 2012). Indeed, the impact on
ecosystems of the decline of the seven largest carnivores in the
world has been recorded in recent decades and the disappearance
of a large carnivore always alters deeply the ecosystem and more
particularly, it reduces its biodiversity (Ripple et al., 2014).
Predators and Preys are in a Dynamic
Equilibrium in Healthy Ecosystems
It thus appears that experimentally, species diversity can be
maintained by predation. In the absence of predators, a few
dominant species can grow rapidly and then supplant many
of the other species, limiting the amount of their available
resources. Conversely, the presence of predators limits the
population of dominant species. The current working paradigm
for community dynamics -understudied in the human gut- is
the Lotka Voltera model. Colloquially known as Kill-the-Winner,
the Lotka Voltera model predicts that predators will rapidly and
drastically reduce the population of the most abundant species,
preventing the best competitors from building up a high biomass.
The role of a predator population inmaintaining species diversity
has been assessed by computer simulations, which displayed
the robustness of the “Lotka-Volterra-like” cycle and implies
that frequent predation might be a mechanism to maintain
species diversity in nature. Moreover, combining the classical
Lotka–Volterra model of population dynamics with regression
techniques provides a mechanistic scheme that can be used to
construct predictive models of ecosystem dynamics. Such an
approach has been successfully applied to the gut microbiota
ecosystem to show which network elements are disrupted during
ATB course and predict to what extend Clostridium difficile
infection (CDI) can arise (Stein et al., 2013). In the same way,
it should be possible to design a mathematical models including
predation within the gut microbial community (Figure 2). Such
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FIGURE 2 | Environmental factors reduce microbial diversity because
of the loss of predatory species. Gut microbiota may be seen as a complex
network of many interacting species (nodes) with several kinds of interactions
(links). Predators (in red) are key species that maintain the diversity of the
microbiota by direct impact on preys (yellow) and indirect effect on other
related species (blue). According to Voltera equations, loss of predators
causes an increase number of preys but a loss of diversity. We propose that in
industrialized countries environmental risk factors reduces the predators in the
network causing LOMD.
model would be validated by new in vitro data issued from studies
on microbial predation in animal’s gut.
Lack of Resilience and Stability Are Major
Consequences of Lomd on Ecosystems
The stability of microbial ecosystem can be analyzed through
predictive or mechanistic models. On one hand, microbial
communities tend to be more phylogenetically clustered than
expected by chance. For instance, in aquatic ecosystems, the
response to disturbance has been linked to the community
network (Hunt and Ward, 2015). Then, a predictive model can
be drawn to predict reactions to disturbance in a particular
community. Within the gut microbiota community, where
microbes compete and cooperate, such network has also been
highlighted. Indeed, co-occurrence of microbial species are
commonly measured in the gut microbiota (Faust et al.,
2012).
On the other hand, in large ecosystems, a decrease of
resilience is often associated with the lack of biodiversity.
Resilience is defined as the amount of disturbance a system can
absorb while remaining in the same functional state. It also refers
to the ability of an altered ecosystem to reorganize and renew in
case of failure. Through the diversity/versatility of each species
response to external or internal changes, a high biodiversity helps
to maintain a stable ecosystem function called “robustness” or
stability (Elmqvist et al., 2003). Coral reefs around Jamaica are
an example of such a phenomenon (Hughes, 1994). Overfishing
led to a loss of diversity in the functional group of “grazers,” but
that loss was made up by an increase in sea urchins, which offsets
the loss of other herbivores and maintained corals as in “healthy
state.” However, when a pathogen reduced the population of sea
urchins (Lessios et al., 1984; Nyström et al., 2000) there were no
grazing species left to prevent the invasion of algae that leads to
FIGURE 3 | Mapping concept of microbiota dysbiosis and resilience.
(A) In a healthy state, the gut microbiota ecosystem (represented by a ball) is in
a steady state (H). The depth of the well in which the ball is located represents
its resilience (R). In case of disturbance (d; i.e., ATB course or digestive
infection), the gut microbiota changes (H′) and then get back to its anterior
state (H). (B) Environmental factors (i.e., western lifestyle) negatively impact the
diversity of the microbiota resulting in a decrease of resilience (R′ <R).
However, the microbiota still remains in an apparent healthy state, due to the
functional redundancy of the ecosystem (H). (C) But in this new situation, the
same disturbance (d) results in a shift of the gut microbiota balance to an other
state called dysbiosis (D). This new state is also a steady state, but it impacts
negatively the individual condition. It represents an “unhealthy” state. (D,E)
“Rebiosis” with respective effect of probiotics administration and fecal
transplantation on the the gut microbiota ecosystem. A single strain (probiotic)
fails to restore a “healthy” ecosystem (D), but a radical change of the
ecosystem through fecal transplantation could be able to achieve this goal (E).
p, probiotics; FT, Fecal Transplant.
the “undesirable state.” In other words, the “diversity of response
increases the tolerance for management of mistakes” (Elmqvist
et al., 2003; Figures 3A–C).
PREDATORS INSIDE THE GUT
Similarly to macro-ecosystems where the influence of human
activity reduces biodiversity by the reduction of large predators,
we hypothesize that the Western lifestyle reduces the diversity of
the intestinal microbiota by loss of bacterial predation. Several
microorganisms such as protists, bacteriophages and predatory
bacteria are known to be predators of components of the gut
microbiota.
Protists
Amoebas have developed complex interactions with bacteria
during evolution (Cosson and Soldati, 2008). Basically, their
interaction is a predator-preymodel for which several parameters
have been described. Differences in susceptibility to predation
differentiate bacterial species (e.g., medium-sized bacteria are
most vulnerable to predation while bacteria with small and large
filamentous forms are partially resistant to predation). Direct and
indirect influences of predation on the conditions of bacterial
growth (substrate supply) or bacterial competition (elimination
of competitors) are also important. In soils, this relationship
seems even more complex, since under favorable environmental
conditions, the interaction between amoebae and non-virulent
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bacteria causes lysis of the bacteria, while the interaction with
low-virulent bacteria causes a symbiotic relationship or amoebic
lysis (Ronn et al., 2002). Interestingly, the hypothesis that protist
predation could shape the gut microbiota diversity has been
recently supported by the discovery of an association between the
absence of commensal amoebas in the intestine of West African
subjects and LOMD (Morton et al., 2015).
Bacteriophages
Bacteriophages, or phages, are the most abundant biological
group on Earth. Phages essentially belong to two categories,
virulent and temperate. The virulent phage lifecycle consists
in replicating in, and then lysing its bacterial host. Temperate
phages can alternate between two lifestyles: they either lyse their
host, like virulent phages, or establish a symbiosis with it, the
so-called “lysogeny state.” In most ecosystems, where phages
outnumber bacteria by a 10-fold factor, predation by phages
allows maintaining bacterial diversity (Rodriguez-Valera et al.,
2009). However, in humans, only 108 phages vs. 1012 bacteria /g
of feces were reported with a preferentially lysogenic phenotype
in the colon of healthy people (Mills et al., 2013). Moreover,
phages cannot move to go and meet their prey and are therefore
subject to a “random collision.” Consequently, viral-bacterial
predator dynamic, evident in a number of other characterized
ecosystems as aquatic environment (Rodriguez-Valera et al.,
2009), could be absent in the distal intestine of healthy individuals
(Reyes et al., 2010, 2013). Thus, they may not be considered “key
predatory.”
Predatory Bacteria
To date, the most studied predatory bacteria belong to the
Bdellovibrio-and-like organisms group called BALOs. The first
report of B. bacteriovorus, gen. et sp. n. was made by Stolp
and Starr in 1963 (Stolp and Starr, 1963) as a predatory and
bacteriolytic microorganism. Bdellovibrio bacteriovorus (Bdello)
is a microaerophilic species from the δ Proteobacteria group
naturally present in soils (rhizosphere) and freshwater but also
in the human intestine (Iebba et al., 2013). It is a highly motile
bacterium that seeks out a prey bacterium and invades it. The
ensuing intracellular growth and replication lead to the lysis
of the prey bacterium and then motile predators are released
(Strauch et al., 2007). It is a non-specific predator of Gram-
negative bacteria but it is not pathogenic for higher organisms
(Dashiff et al., 2011). Beyond this direct predation against
gram-negative bacteria, it even impacts the growth of Gram
positive bacteria such as Staphylococcus aureus (Iebba et al., 2014;
Monnappa et al., 2014).
Despite its broad spectrum of activity on many gram negative
bacteria (Dashiff et al., 2011; Kadouri et al., 2013), its impact
on the intestinal microbiota has not been studied. So far, it
has mainly been studied as a potential alternative to antibiotics
(Sockett and Lambert, 2004; Dwidar et al., 2012) for ocular
(Shanks et al., 2013), periodontal (Van Essche et al., 2011),
or respiratory infections (Iebba et al., 2014). The only report
of oral administration of Bdello showed a 10-fold decrease
of Salmonella enteritidis and a reduction of morphological
abnormalities associated with the cecum infection in infected
chicken (Atterbury et al., 2011). The effects of Bdello on
oral microbiota were recently analyzed using high throughput-
sequencing methods (Loozen et al., 2015). Ex vivo experiments
performed on sub-gingival plaque and saliva samples from
periodontitis patients demonstrated changes in the overall
ecology. Unfortunately, the effect on bacterial diversity was not
specifically assessed. However, the evidence of coevolution of
Bdello and its preys according to the Red Queen theory has
been made by a long-term experiment involving Bdello and its
prey Pseudomonas fluorescens (Gallet et al., 2009), indicating
that Bdello could drive the biodiversity in the ecosystem when
present.
PREDATORS, MICROBIOTA DIVERSITY
AND HEALTH: CLINICAL PERSPECTIVES
Microbiota Diversity and the Host Immune
System: A Key Point
Predatory-preys interactions were operating among bacteria
long before the appearance of animals on earth. Then, animals
provided new surroundings for bacteria, resulting in a more
complex interaction between host cells and microorganisms. For
instance, gut microbiota in vertebrates’ gut adapts to the host
diet over daily time scales, as we already mentioned (Graf et al.,
2015), but even over evolutionary scales. This allowed animals to
face environmental changes as they were able to digest a broad
variety of biomolecules (Ley et al., 2008). Moreover, it has been
proposed that this microbial functional diversity would have been
beneficial for the host in an evolutionary perspective since it
might have shaped the adaptive immune system (McFall-Ngai,
2007; McFall-Ngai et al., 2013).
Although many studies assessed the impact of single bacterial
species on inflammatory markers, few of them looked at the
relationship between microbiota diversity and its consequences
on the immune system. One of the major components of the
adaptive immune system are the CD4+ regulatory T (Treg) cells,
which express the transcription factor Foxp3 and play an essential
role in maintaining the immune homeostasis. Gnotobiotic mice
colonized with 3 strains of Clostridium were shown to display a
profile of Treg induction intermediate between axenic animals
and mice inoculated with 46 strains. This observation suggests
that an optimal induction of Tregs requires a set of metabolites
that are more efficiently produced by a panel of Clostridium
strains (Atarashi et al., 2011). On the other hand, axenic mice
and those with low microbiota diversity develop high levels of
serum IgE early in life (Cahenzli et al., 2013). Finally, an antibiotic
treatment with vancomycin reduced the microbial diversity and
increased the severity of asthmatic disease in mice (Russell et al.,
2012).
Crohn’s Disease: A Typical Example of the
Interaction between Western Lifestyle and
Dysbiosis, Where Bdello Could Play a Role
CD typically represents a chronic inflammatory disease whose
incidence increased sharply in Western countries (Molodecky
et al., 2012) with large variations between Westernized and
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developing countries (Ng et al., 2013). It is also a disease for which
epidemiological studies have linked low exposure to infectious
agents and disease occurrence. For example, the farm life in
childhood would protect against the disease (Amre et al., 2006).
ATB taken in childhood increase the risk of CD (Shaw et al.,
2010; Hviid et al., 2011; Ungaro et al., 2014). CD is also associated
with a dysbiosis with a significant reduction in bacterial diversity
(Manichanh et al., 2006; Dey et al., 2013; Sha et al., 2013). Finally,
the presence of Bdello in stools and intestinal biopsies of children
with CD has recently been studied. Only one out of nine patients
carried Bdello while healthy eight controls were all positive (Iebba
et al., 2013).
What would be the consequences of Bdello decrease in
CD? Firstly, Bdello having a predation predominant on Gram
negative bacteria, its absence could result in a proliferation of
“pathobiont” bacteria, like Adherent and Invasive Escherichia
coli (AIEC) or Yersinia species which are suspected to play a
role in CD lesions (Carrière, 2014). Secondly, it can explain
the observed increased proportion of Gram-negative symbionts
(for example Bacteroides from the Bacteroidetes phylum) with
a subsequent decrease of Gram positive bacteria such as
Faecalibacterium prausnitzii from the Clostridium leptum group
within the Firmicutes observed in CD patients. As a whole,
CD could thus represent a prototypic example of the proposed
theory.
“Rebiosis” or How to Restore the Microbial
Diversity?
Since the discovery of disease-associated dysbiosis, it is now
accepted that a therapeutic goal is to restore a “healthy” or
balanced microbiota, notably by improving the gut microbiota
diversity. Several therapeutic attempts have been considered. Elie
Metchnikoff first wrote about the health benefits of probiotics. He
observed that Bulgarian peasants who consumed large amounts
of fermented milk, the early form of yogurt, lived longer and
healthier. For over a century, probiotics have been used in a
large number of diseases, but with disappointing results (Quigley,
2010), even in CD (Orel, 2014). The rationale could be that
providing one or a handful of strains may not be sufficient
to restore a functionally compromised ecosystem (Figure 3D).
As a matter of fact, it was recently shown that some probiotic
strains delivered to the mothers failed to increase the microbiota
diversity in their offspring’s (Dotterud et al., 2015).
To restore the diversity, transplantation of fecal microbiota
has been proposed. This drastic therapy, described in China
as early as in the fourth century, was occasionally used
as a treatment for severe and ATB resistant Clostridium
difficile colitis during the twentieth century (Vrieze et al.,
2013). Recently, the European Society of Clinical Microbiology
and Infectious Diseases has included this approach for the
treatment of CDI (Debast et al., 2014) (Figure 3E). In the
same line, the “Repopulate” study proposed a cocktail of 33
species cultured from stools of a single donor. Two patients
were effectively treated for CDI and the bacterial populations
persisted in the recipient colon for over 6 months after the
transplantation.
Alternatively, If our theory is true, an option could be to
reintroduce predators in order to restore the microbial diversity
and health.
CONCLUSION
Over the last few years, data linking LOMD and Human
diseases associated with the westernized lifestyle has been
accumulating. We hypothesize that the modern western lifestyle
may be associated with a loss of predators within the
microbiota ecosystem as demonstrated in macro-ecological
models. According to this hypothesis, the lack of predation
and LOMD could lead to an unstable microbial ecosystem.
The consequent instability could favor the emergence of
dysbiotic microbiota giving rise to immunological or metabolic
diseases. If demonstrated, this point of view might bring
a significant impact on understanding and treating these
diseases.
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GLOSSARY
- Intestinal dysbiosis: Distinct definitions of dysbiosis can
be found from the literature. In practice, dysbiosis refers to
microbiota that differs from the one of healthy people. We chose
the definition of Petersen and Round (Petersen and Round, 2014)
because it seems relevant here since it is linked to its impact
on host immunity. According to, dysbiosis can be defined by
three main features, (i) a loss of beneficial microbial organisms,
(ii) the expansion of pathobionts, and (iii) a loss of microbial
diversity.
-Diversity metrics:
- Richness: Number of taxonomic units (e.g., species) in
a community, standardized to the number of individuals
sampled.
- Alpha diversity: An inventory metric that expresses
the amount of local diversity or diversity at the smallest
spatial scale of analysis (e.g., Intra individual gut microbiota
diversity). Assessed by Shannon or Simplon index for example.
LOMD refers to alpha diversity.
- Beta diversity: A differentiation diversity metric that refers
to turnover at the landscape scale, i.e., turnover between local
populations (e.g., inter-individual gut microbiota diversity
within the same population): not used in this paper.
- Gamma diversity: is a similar metric used to refer
to diversity at the regional scale (e.g., between different
population: westernized vs. non westernized): not used in this
paper).
- Community: A group of potentially interacting species that
co-occur in space and time (e.g., gut microbiota).
-Resilience and stability: The stability of an ecosystem is defined
as a community’s response to disturbance. It depends on the
resistance (insensitivity to disturbance) and the resilience of the
ecosystem (Shade et al., 2012). The resilience is the rate at which
a microbial community returns to its original composition after
being disturbed (Allison and Martiny, 2008). Then, it represents
a measure of the ability of this system to absorb changes and still
persist. In this definition, resilience is the property of the system
and persistence or probability of extinction is the result (Holling,
1973).
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